Advertisement
UK markets close in 3 minutes
  • FTSE 100

    8,353.72
    +40.05 (+0.48%)
     
  • FTSE 250

    20,441.32
    +28.24 (+0.14%)
     
  • AIM

    779.44
    +3.02 (+0.39%)
     
  • GBP/EUR

    1.1622
    -0.0002 (-0.02%)
     
  • GBP/USD

    1.2493
    -0.0016 (-0.13%)
     
  • Bitcoin GBP

    49,580.62
    -1,487.81 (-2.91%)
     
  • CMC Crypto 200

    1,324.78
    +30.11 (+2.32%)
     
  • S&P 500

    5,185.16
    -2.54 (-0.05%)
     
  • DOW

    38,980.40
    +96.14 (+0.25%)
     
  • CRUDE OIL

    78.60
    +0.22 (+0.28%)
     
  • GOLD FUTURES

    2,321.70
    -2.50 (-0.11%)
     
  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     
  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     
  • DAX

    18,477.99
    +47.94 (+0.26%)
     
  • CAC 40

    8,141.58
    +65.90 (+0.82%)
     

OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024

OrthoPediatrics Corp.
OrthoPediatrics Corp.

WARSAW, Ind., April 22, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2024 financial results on Monday, May 6, 2024, after the market closes. OrthoPediatrics will host a conference call on Tuesday, May 7, 2024, at 8:00 a.m. ET to discuss the results.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event.

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 71 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 71 countries outside the United States. For more information, please visit www.orthopediatrics.com.

Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com 
415-937-5406